Advertisement

TCI/TIVA Adult Case Studies

  • Nicholas SutcliffeEmail author
Chapter

Abstract

Total intravenous anaesthesia (TIVA) has many potential benefits, despite this, in many countries rates of TIVA remain low and education in the technique is lacking. This chapter considers the merits of Target Controlled Infusion (TCI) versus Manual Controlled Infusion (MCI), going on to consider appropriate dosing regimens for both hypnotic and opiate infusions. Detailed case studies are presented of induction and maintenance of general anesthesia and sedation. Appropriate doses in real life clinical scenarios are considered together with supporting evidence from published studies. A consideration of hypnotic/opiate interaction is also presented.

Keywords

Adults Anaesthesia, intravenous Anaesthetics, intravenous/pharmacokinetics Anaesthetics, intravenous/pharmacodynamics Clinical pharmacology Hypnotics and sedatives/administration and dosage Models, statistical Models, biological Propofol/pharmacokinetics Propofol/pharmacodynamics 

Supplementary material

(MP4 9652 KB)

References

  1. 1.
    Pandit JJ, Cook TM. Fifth National Audit Project of the Royal College of Anaesthetists in collaboration with the Association of Anaesthetists of Great Britain and Ireland: Accidental Awareness during General Anaesthesia in the United Kingdom and Ireland 2014. http://www.nationalauditprojects.org.uk/NAP5home.
  2. 2.
    Madhivathanan P, Kasivisvanathan R, Cohen A. Training in total intravenous anaesthesia: a regional survey. Anaesthesia. 2010;65(5):540–2.CrossRefGoogle Scholar
  3. 3.
    Leslie K, Clavisi O, Hargrove J. Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults. Cochrane Database Syst Rev. 2008;16(3):CD006059.Google Scholar
  4. 4.
    Mazzarella B, Melloni C, Montanini S, Novelli GP, Peduto VA, Santandrea E, Vincenti E, Zattoni J. Comparison of manual infusion of propofol and target-controlled infusion: effectiveness, safety and acceptability. Minerva Anestesiol. 1999;65(10):701–9.Google Scholar
  5. 5.
    Marsh B, White M, Morton N, Kenny GNC. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67:41–8.Google Scholar
  6. 6.
    Peacock JE, Lewis RP, Reilly CS, Nimmo WS. Effect of different rates of infusion of propofol for induction of anaesthesia in elderly patients. Br J Anaesth. 1990;65(3):346–52.Google Scholar
  7. 7.
    Dundee JW, Robinson FP, McCollum JS, Patterson CC. Sensitivity to propofol in the elderly. Anaesthesia. 1986;41(5):482–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Milne SE, Kenny GNC, Schraag S. Propofol sparing effect of remifentanil using closed-loop anaesthesia. Br J Anaesth. 2003;90(5):623–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Tzabar Y, Brydon C, Gillies GW. Induction of anaesthesia with midazolam and a target controlled propofol infusion. Anaesthesia. 1996;53(6):1–86.Google Scholar
  10. 10.
    Vuyk J, Mertens MJ, Olofsen E, Burm AG, Bovill JG. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology. 1997;87(6):1549–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Davidson JA, Macleod AD, Howie JC, White M, Kenny GN. Effective concentration 50 for propofol with and without 67% nitrous oxide. Acta Anaesthesiol Scand. 1993;37(5):458–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Mertens MJ, Engbers FH, Burm AG, Vuyk J. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia. Br J Anaesth. 2003;90(2):132–41.CrossRefPubMedGoogle Scholar
  13. 13.
    Vuyk J, Lim T, Engbers FH, Burm AG, Vletter AA, Bovill JG. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology. 1995;83(1):8–22.CrossRefPubMedGoogle Scholar
  14. 14.
    Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuchi R. Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther. 2004;75:324–30.CrossRefPubMedGoogle Scholar
  15. 15.
    Takizawa E, Hiraoka H, Takizawa D, Goto F. Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. Br J Anaesth. 2006;96:179–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Schuller PJ, Newell S, Strickland PA, Barry JJ. Response of bispectral index to neuromuscular block in awake volunteers. Br J Anesth. 2015;i95–i103.Google Scholar
  17. 17.
    Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88(5):1170–82.Google Scholar
  18. 18.
    Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ. The influence of age on propofol pharmacodynamics. Anesthesiology. 1999;90(6):1502–16.CrossRefPubMedGoogle Scholar
  19. 19.
    Barakat A, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia. 2007;(5):661–6.Google Scholar
  20. 20.
    Lu Y, Hao LX, Chen LX, Jin Z, Gong B. Systematic review and meta-analysis of patient-controlled sedation versus intravenous sedation for colonoscopy. Int J Clin Exp Med. 2015;8(11):19793–803.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Leitch JA, Sutcliffe N, Kenny GN. Patient-maintained sedation for oral surgery using a target-controlled infusion of propofol - a pilot study. Br Dent J. 2003;194(1):43–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Hamad Medical Corporation, Hamad Medical CityDohaQatar

Personalised recommendations